Chatellier G, Colombet I, Degoulet P
Broussais University Hospital, Paris, France.
Stud Health Technol Inform. 1998;52 Pt 2:819-23.
Risks and benefits of anticoagulant therapy depend directly of the quality of anticoagulation. We performed a meta-analysis of published randomized trials to assess the overall effectiveness of computer-based prescription systems on the quality of anticoagulation.
Randomized controlled trials were identified through electronic searches of the Medline database (1966-1997) and systematic analyses of the references of articles. Two investigators selected relevant papers and summarized data from the studies.
The outcome variable was the proportion of days within the target range of anticoagulation. A pooled estimate of the common odds ratio of being in the target range and its confidence interval was obtained by the Mantel-Haenszel method.
Seven trials having included 1217 patients were identified. Computer systems were based on a pharmacokinetic-pharmacodynamic model and a bayesian prediction method. Most of them concerned the oral anticoagulant warfarin. The global odds ratio of being in the target range was 1.58 [95% CI: 1.34-1.86], thus meaning that the use of a computer for anticoagulation optimization increased by 58% the proportion of visits where patients were appropriately treated. The proportion of clinical events was too low for allowing a summary analysis.
Evidence from randomized controlled trials supports the effectiveness of computer-aided anticoagulant prescription. Diffusion of these systems in ambulatory care could increase the benefit/risk ratio of anticoagulant treatment at a low cost.
抗凝治疗的风险和益处直接取决于抗凝的质量。我们对已发表的随机试验进行了一项荟萃分析,以评估基于计算机的处方系统在抗凝质量方面的总体有效性。
通过对Medline数据库(1966 - 1997年)进行电子检索以及对文章参考文献进行系统分析来确定随机对照试验。两名研究人员选择相关论文并汇总研究数据。
结果变量是抗凝处于目标范围内的天数比例。通过Mantel - Haenszel方法获得处于目标范围内的共同优势比及其置信区间的合并估计值。
确定了7项试验,共纳入1217名患者。计算机系统基于药代动力学 - 药效学模型和贝叶斯预测方法。其中大多数涉及口服抗凝剂华法林。处于目标范围内的总体优势比为1.58 [95%置信区间:1.34 - 1.86],这意味着使用计算机进行抗凝优化可使患者得到适当治疗的就诊比例提高58%。临床事件的比例过低,无法进行汇总分析。
随机对照试验的证据支持计算机辅助抗凝处方的有效性。这些系统在门诊护理中的推广应用可以低成本提高抗凝治疗的效益/风险比。